|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
2005.
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003.
|
|
3
|
Mishima T, Akagi I, Miyashita M, Ishibashi
O, Mizuguchi Y, Tajiri T, et al: Study of microRNA expression
profiles of esophageal cancer. J Nippon Med Sch. 76:432009.
|
|
4
|
Lakshmipathy U and Hart RP: Concise
review: microRNA expression in multi-potent mesenchymal stromal
cells. Stem Cells. 26:356–363. 2008.
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, et al: Human microRNA genes are frequently
located at fragile sites and genomic regions involved in cancers.
Proc Natl Acad Sci USA. 101:2999–3004. 2004.
|
|
6
|
Tsai WC, Hsu PW, Lai TC, et al:
MicroRNA-122, a tumor suppressor microRNA that regulates
intrahepatic metastasis of hepatocellular carcinoma. Hepatology.
49:1571–1582. 2009.
|
|
7
|
Ferdin J, Kunej T and Calin GA: Non-coding
RNAs: identification of cancer-associated microRNAs by gene
profiling. Technol Cancer Res Treat. 9:123–138. 2010.
|
|
8
|
Paranjape T, Slack FJ and Weidhaas JB:
MicroRNAs: tools for cancer diagnostics. Gut. 58:1546–1554.
2009.
|
|
9
|
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek
SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II.
EMBO J. 23:40512–4060. 2004.
|
|
10
|
Cho WC: MicroRNAs in cancer - from
research to therapy. Biochim Biophys Acta. 1805:209–217. 2010.
|
|
11
|
Cai X, Hagedorn CH and Cullen BR: Human
microRNAs are processed from capped, polyadenylated transcripts
that can also function as mRNAs. RNA. 10:19572–1966. 2004.
|
|
12
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, et al: The nuclear RNase III Drosha initiates
microRNA processing. Nature. 425:415–419. 2003.
|
|
13
|
Bohnsaek MT, CzaPlinski K and Gorlieh D:
Exportin5 is a RanGTP-dependent dsRNA-binding protein that mediates
nuclear export of pre-miRNAs. RNA. 10:185–191. 2004.
|
|
14
|
Denli AM, Tops BB, Plasterk RH, Ketting RF
and Hannon GJ: Processing of primary microRNAs by the
Microprocessor complex. Nature. 432:231–235. 2004.
|
|
15
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005.
|
|
16
|
Joshua-Tor L: The Argonautes. Cold Spring
Harb Symp Quant Biol. 71:67–72. 2006.
|
|
17
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
2006.
|
|
18
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
19
|
Wang B, Doench JG and Novina CD: Analysis
of microRNA effector functions in vitro. Methods. 43:91–104.
2007.
|
|
20
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, et al: Frequent deletions and
down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in
chronic lymphocytic leukemia. Proc Natl Acad Sci USA.
99:15524–15529. 2002.
|
|
21
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, et al: miR-15 and miR-16 induce apoptosis by
targeting BCL2. Proc Natl Acad Sci USA. 102:13944–13949. 2005.
|
|
22
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, et al: Reduced expression of the let-7 microRNAs
in human lung cancers in association with shortened postoperative
survival. Cancer Res. 64:3753–3756. 2004.
|
|
23
|
Johnson SM, Lin SY and Slack FJ: The time
of appearance of the C. elegans let-7 microRNA is
transcriptionally controlled utilizing a temporal regulatory
element in its promoter. Dev Biol. 259:364–379. 2003.
|
|
24
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: miR-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007.
|
|
25
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, et al: Cyclin G1 is a target of
miR-122a, a microRNA frequently down-regulated in human
hepatocellular carcinoma. Cancer Res. 67:6092–6099. 2007.
|
|
26
|
Raver-Shapira N, Marciano E, Meiri E,
Spector Y, Rosenfeld N, et al: Transcriptional activation of
miR-34a contributes to p53-mediated apoptosis. Mol Cell.
26:731–743. 2007.
|
|
27
|
Raver-Shapira N and Oren M: Tiny actors,
great roles: microRNAs in p53's service. Cell Cycle. 6:2656–2661.
2007.
|
|
28
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009.
|
|
29
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008.
|
|
30
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009.
|
|
31
|
Latronico MV, Catalucci D and Condorelli
G: MicroRNA and cardiac pathologies. Physiol Genomics. 34:239–242.
2008.
|
|
32
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, et al: A miRNA polycistron as a
potential human oncogene. Nature. 435:828–833. 2005.
|
|
33
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.
|
|
34
|
Mu P, Han YC, Betel D, Yao E, Squatrito M,
Ogrodowski P, et al: Genetic dissection of the miR-17-92 cluster of
microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23:2806–2811.
2009.
|
|
35
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007.
|
|
36
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007.
|
|
37
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, et al: MicroRNA expression profiles of
esophageal cancer. J Thorac Cardiovasc Surg. 135:255–260. 2008.
|
|
38
|
Guo Y, Chen Z, Zhang L, Shi S, Feng X, et
al: Distinctive microRNA profiles relating to patient survival in
esophageal squamous cell carcinoma. Cancer Res. 68:26–33. 2008.
|
|
39
|
Mathé EA, Nguyen GH, Bowman ED, Zhao Y,
Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et
al: MicroRNA expression in squamous cell carcinoma and
adenocarcinoma of the esophagus: associations with survival. Clin
Cancer Res. 15:6192–6200. 2009.
|
|
40
|
Kan T and Meltzer SJ: MicroRNAs in
Barrett's esophagus and esophageal adenocarcinoma. Curr Opin
Pharmacol. 9:727–732. 2009.
|
|
41
|
Maru DM, Singh RR, Hannah C, Albarracin
CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy
S, et al: MicroRNA-196a is a potential marker of progression during
Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in
esophagus. Am J Pathol. 174:1940–1948. 2009.
|
|
42
|
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Katada T, Harata K, Tanaka T and Fujii Y: Expression
profiling of micro-RNAs in human esophageal squamous cell carcinoma
using RT-PCR. Med Mol Morphol. 42:102–109. 2009.
|
|
43
|
Zhang T, Zhao D, Wang Q, Yu X, Cui Y, Guo
L and Lu SH: MicroRNA-1322 regulates ECRG2 allele specifically and
acts as a potential biomarker in patients with esophageal squamous
cell carcinoma. Mol Carcinog. Feb 7–2012.(Epub ahead of print).
|
|
44
|
Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF,
Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM and Xu LY: MiR-142-3p as
a potential prognostic biomarker for esophageal squamous cell
carcinoma. J Surg Oncol. 105:175–182. 2012.
|
|
45
|
Leidner RS, Ravi L, Leahy P, Chen Y,
Bednarchik B, Streppel M, Canto M, Wang SJ, Maitra A, Willis J, et
al: The microRNAs, MiR-31 and MiR-375, as candidate markers in
Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer.
51:473–479. 2012.
|
|
46
|
Hu Y, Correa AM, Hoque A, Guan B, Ye F,
Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic
significance of differentially expressed miRNAs in esophageal
cancer. Int J Cancer. 128:132–143. 2011.
|
|
47
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 28;105:104–111.
2011.
|
|
48
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: a fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010.
|
|
49
|
Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo
L and Lu SH: The oncogenetic role of microRNA-31 as a potential
biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond).
121:437–447. 2011.
|
|
50
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010.
|
|
51
|
Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF,
Huang Q, Fang GQ and Li EM: MiRNA profile in esophageal squamous
cell carcinoma: downregulation of miR-143 and miR-145. World J
Gastroenterol. 17:79–88. 2011.
|
|
52
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010.
|
|
53
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010.
|
|
54
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011.
|
|
55
|
Li S, Li Z, Guo F, Qin X, Liu B, Lei Z,
Song Z, Sun L, Zhang HT, You J and Zhou Q: miR-223 regulates
migration and invasion by targeting Artemin in human esophageal
carcinoma. J Biomed Sci. 18:242011.
|
|
56
|
Hummel R, Hussey DJ, Michael MZ, Haier J,
Bruewer M, Senninger N and Watson DI: miRNAs and their association
with locoregional staging and survival following surgery for
esophageal carcinoma. Ann Surg Oncol. 18:253–260. 2011.
|
|
57
|
Mori Y, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Ogawa R, Katada T, Harata K, Tanaka T, Shiozaki M and
Fujii Y: MicroRNA-21 induces cell proliferation and invasion in
esophageal squamous cell carcinoma. Mol Med Rep. 2:235–239.
2009.
|
|
58
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M
and Baba H: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009.
|
|
59
|
Ma WJ, Lv GD, Tuersun A, Liu Q, Liu H,
Zheng ST, Huang CG, Feng JG, Wang X, Lin RY, Sheyhidin I and Lu XM:
Role of microRNA-21 and effect on PTEN in Kazakh's esophageal
squamous cell carcinoma. Mol Biol Rep. 38:3253–3260. 2011.
|
|
60
|
Feber A, Xi L, Pennathur A, Gooding WE,
Bandla S, Wu M, Luketich JD, Godfrey TE and Litle VR: MicroRNA
prognostic signature for nodal metastases and survival in
esophageal adenocarcinoma. Ann Thorac Surg. 91:1523–1530. 2011.
|
|
61
|
Ohashi S, Natsuizaka M, Naganuma S, Kagawa
S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, et
al: NOTCH3-mediated squamous cell differentiation program limits
expansion of EMT-competent cells that express the ZEB transcription
factors. Cancer Res. 71:6836–6847. 2011.
|
|
62
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011.
|
|
63
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012.
|
|
64
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012.
|
|
65
|
Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J,
Wang Z, Tan FW and Tan XG: miR-29c induces cell cycle arrest in
esophageal squamous cell carcinoma by modulating cyclin E
expression. Carcinogenesis. 32:1025–1032. 2011.
|
|
66
|
Kan T, Sato F, Ito T, Matsumura N, David
S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, et al: The
miR-106b-25 polycistron, activated by genomic amplification,
functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 136:1689–1700. 2009.
|
|
67
|
He L, He X, Lim LP, de Stanchina E, et al:
A microRNA component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007.
|
|
68
|
Wijnhoven BP, Hussey DJ, Watson DI, Tsykin
A, Smith CM, et al: microRNA profiling of Barrett's oesophagus and
oesophageal adenocarcinoma. Br J Surg. 97:853–861. 2010.
|
|
69
|
Lee KH, Goan YG, Hsiao M, Lee CH, et al:
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor
suppressor, homolog2 (LATS2) and stimulates proliferation in human
esophageal cancer. Exp Cell Res. 315:2529–2538. 2009.
|
|
70
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678.
2008.
|
|
71
|
Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J,
Cheng HZ and Huang SD: MicroRNA-203 inhibits cell proliferation by
repressing ΔNp63 expression in human esophageal squamous cell
carcinoma. BMC Cancer. 11:572011.
|
|
72
|
Liu M, Wang Z, Yang S, Zhang W, He S, Hu
C, Zhu H, Quan L, Bai J and Xu N: TNF-α is a novel target of
miR-19a. Int J Oncol. 38:1013–1022. 2011.
|
|
73
|
Tsuchiya S, Fujiwara T, Sato F, Shimada Y,
Tanaka E, Sakai Y, Shimizu K and Tsujimoto G: MicroRNA-210
regulates cancer cell proliferation through targeting fibroblast
growth factor receptor-like 1 (FGFRL1). J Biol Chem. 286:420–428.
2011.
|
|
74
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: the implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010.
|
|
75
|
Wang K, Guo H, Hu H, Xiong G, Guan X, Li
J, Xu X, Yang K and Bai Y: A functional variation in
pre-microRNA-196a is associated with susceptibility of esophageal
squamous cell carcinoma risk in Chinese Han. Biomarkers.
15:614–618. 2010.
|
|
76
|
Ye Y, Wang KK, Gu J, Yang H, et al:
Genetic variations in microRNA-related genes are novel
susceptibility loci for esophageal cancer risk. Cancer Prev Res
(Phila). 1:460–469. 2008.
|
|
77
|
Guo H, Wang K, Xiong G, Hu H, Wang D, Xu
X, Guan X, Yang K and Bai Y: A functional variant in microRNA-146a
is associated with risk of esophageal squamous cell carcinoma in
Chinese Han. Fam Cancer. 9:599–603. 2010.
|
|
78
|
Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou
C and Zhou J: A miR-200b/200c/429-binding site polymorphism in the
3′ untranslated region of the AP-2α gene is associated with
cisplatin resistance. PLoS One. 6:e290432011.
|
|
79
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
|
|
80
|
Saito Y, Liang G, Egger G, Friedman JM,
Chuang JC, Coetzee GA and Jones PA: Specific activation of
microRNA-127 with downregulation of the proto-oncogene BCL6 by
chromatin-modifying drugs in human cancer cells. Cancer Cell.
9:435–443. 2006.
|
|
81
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008.
|
|
82
|
Li X, Lin R and Li J: Epigenetic silencing
of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig
Dis Sci. 56:2849–2856. 2011.
|
|
83
|
Chen X, Hu H, Guan X, Xiong G, Wang Y,
Wang K, Li J, Xu X and Yang K: CpG island methylation status of
miRNAs in esophageal squamous cell carcinoma. Int J Cancer.
130:1607–1613. 2012.
|
|
84
|
Hummel R, Wang T, Watson DI, Michael MZ,
Van der Hoek M, Haier J and Hussey DJ: Chemotherapy-induced
modification of microRNA expression in esophageal cancer. Oncol
Rep. 26:1011–1017. 2011.
|
|
85
|
Imanaka Y, Tsuchiya S, Sato F, Shimada Y,
Shimizu K and Tsujimoto G: MicroRNA-141 confers resistance to
cisplatin-induced apoptosis by targeting YAP1 in human esophageal
squamous cell carcinoma. J Hum Genet. 56:270–276. 2011.
|
|
86
|
Zhang H, Li M, Han Y, Hong L, Gong T, Sun
L and Zheng X: Down-regulation of miR-27a might reverse multidrug
resistance of esophageal squamous cell carcinoma. Dig Dis Sci.
55:2545–2551. 2010.
|
|
87
|
Hong L, Han Y, Zhang H, Li M, Gong T, Sun
L, Wu K, Zhao Q and Fan D: The prognostic and chemotherapeutic
value of miR-296 in esophageal squamous cell carcinoma. Ann Surg.
51:1056–1063. 2010.
|
|
88
|
Hamano R, Miyata H, Yamasaki M, Kurokawa
Y, Hara J, Moon JH, Nakajima K, Takiguchi S, Fujiwara Y, Mori M and
Doki Y: Overexpression of miR-200c induces chemoresistance in
esophageal cancers mediated through activation of the Akt signaling
pathway. Clin Cancer Res. 17:3029–3038. 2011.
|
|
89
|
Hummel R, Watson DI, Smith C, Kist J,
Michael MZ, Haier J and Hussey DJ: Mir-148a improves response to
chemotherapy in sensitive and resistant oesophageal adenocarcinoma
and squamous cell carcinoma cells. J Gastrointest Surg. 15:429–438.
2011.
|
|
90
|
Zheng ZF, Su HF, Zou Y, Peng Z and Wu SX:
Expression profiles of microRNAs in radioresistant esophageal cell
line. Zhonghua Yi Xue Za Zhi. 91:639–642. 2011.(In Chinese).
|
